Directional cerebrospinal fluid movement between brain ventricles in larval zebrafish RM Fame, JT Chang, A Hong, NA Aponte-Santiago, H Sive Fluids and Barriers of the CNS 13, 1-12, 2016 | 50 | 2016 |
Synaptic Plasticity Induced by Differential Manipulation of Tonic and Phasic Motoneurons in Drosophila NA Aponte-Santiago, KG Ormerod, Y Akbergenova, JT Littleton The Journal of Neuroscience 40 (33), 6270–6288, 2020 | 36 | 2020 |
Synaptic properties and plasticity mechanisms of invertebrate tonic and phasic neurons NA Aponte-Santiago, JT Littleton Frontiers in Physiology 11, 611982, 2020 | 28 | 2020 |
The decoy SNARE Tomosyn sets tonic versus phasic release properties and is required for homeostatic synaptic plasticity CW Sauvola, Y Akbergenova, KL Cunningham, NA Aponte-Santiago, ... Elife 10, e72841, 2021 | 21 | 2021 |
Molecular logic of synaptic diversity between Drosophila tonic and phasic motoneurons SK Jetti, AB Crane, Y Akbergenova, NA Aponte-Santiago, ... Neuron 111 (22), 3554-3569. e7, 2023 | 15 | 2023 |
Tales of the unexpected N Aponte Santiago, S Konecki, L Porter, H Virk Elife 12, e87444, 2023 | 5 | 2023 |
Functional changes in connectivity induced by differential manipulations of activity in Drosophila tonic versus phasic motoneurons NA Aponte Santiago Massachusetts Institute of Technology, 2020 | | 2020 |
Functional characterization of human α7 nicotinic acetylcholine receptor genetic variants (1147.4) C Baez‐Pagan, M Holder‐Viera, Z Santana‐Rodriguez, ... The FASEB Journal 28, 1147.4, 2014 | | 2014 |
Potential implications of human alpha7 nicotinic acetylcholine receptor genetic variants to the pathogenesis and treatment of HIV‐associated neurocognitive disorders M Holder‐Viera, NA Aponte‐Santiago, E Aviles‐Pagan, ... The FASEB Journal 27, lb202-lb202, 2013 | | 2013 |
CHARACTERIZATION OF SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN ALPHA7 NICOTINIC RECEPTOR REVEALS ALTERATIONS IN FUNCTIONALITY AND RESPONSE TO BUPROPION: POTENTIAL … CA Baez-Pagan, E Aviles-Pagan, NA Aponte-Santiago, M Holder-Viera, ... JOURNAL OF NEUROIMMUNE PHARMACOLOGY 8 (2), 408-408, 2013 | | 2013 |